Engliesh version | صفحه اصلی | سایت دانشگاه | اخبار | راهنمای تلفن و پست الکترونیک | پست الکترونیک | پیام نما | تماس با ما | پیوندها

banervasat



president

 

 

 

 

 

semat

 

پیام های بهداشتی



PDF چاپ نامه الکترونیک

                                          Curriculum Vitae ataei

 

    

Personal Information:  

Name: Behrooz – Ataei    

Marital status:  Married    

Number of children: 2    

Academic position:  Assosiate professor     

 

Address:  

Infectious Diseases and Tropical Medicine Research Center. Isfahan University of Medical Sciences. Isfahan-Iran  

Tel: +983113377172                  fax: +983113373735  

E-mail: Ataei @med.mui.ac.ir  

 

Education:  

MD. Isfahan university 1975-1981.  

Especially. Infectious Diseases and Tropical Medicine. Isfahan University. 1991-1995.  

 

Professional experience:  

Head of Infectious Disease and Tropical Medicine Research Center. 2007- present.  

Deputy for Research in Infectious Disease and Tropical Medicine Research Center. 2006-2007.  

Deputy for Manager of treatment. 2003-2004.      

              

Research  Projects:    

1) Head project in: "The comparison of relative frequency of CCHF positive serology in imported and native sheeps at Isfahan province".  

2) Head project in: "The comparison of Quality of life between Patients with Chronic liver disease arising from hepatitis B and C and Control Group in 2004 – 2005".  

3) Head project in: "The prevalence of hepatitis A, B and E virus in Isfahan in 2005-2006". 

4) Head project in:  "The Comparison of two different therapeutic regimens of Dot strategy in patients with pulmonary tuberculosis".  

5) Head project in: "Assessment of the Relative frequency of prevalence of HBV, HCV, HIV in Street Children and teenager in Isfahan city in 2005-2006". 

6) Head project in: "Distribution of ticks and their assessment to Borrelia and CCHF in Isfahan province". 

7) Head project in: "Prevalence of Hepatitis B and C virus Infection in barbers in the Isfahan City – Iran 2007". 

8) Head project in: "Study of dysentery outbreak in Naein & Ardestan, Isfahan by conventional and advanced Molecular Microbiology". 

9) Head project in:  "Prevalence of HDV in chronic carriers of HBV in Isfahan in 2007".

10) Head project in: "Prevalence of Hepatitis B and their Risk Factors in Transit Heavy Vehicle Drivers -2007".

11) Head project in: Screening and survey frequency of pulmonary tuberculosis in patients with chronic cough in Isfahan province. 

12) Head project in: ''The assessment and management of hepatitis C in IVDA in Isfahan province'' 2008.

13) Head project in: "Study of Seroprevalence of hepatitis A virus (HAV) in Fresh College Students of Isfahan, Hamedan, Kermanshah   University of medical sciences".

14) Head project in: "Study of seroprevalence of hepatitis A virus (HAV) in fresh college student of Isfahan, Kermanshah, Hamedan University".  

15) Head project in: "Prevalence of infectious rate and identification of Brucella species in raw milk with Real time PCR system in Isfahan city".

16) Head project in: "Prevalence of infectious rate and identification of Brucella species in dairy product with Real time PCR system in Isfahan city in 1389".  

17) Head project in: "Prevalence and Genotyping of rotavirus in 2-60 month old children with acute diarrhea in ambulatory settings in Isfahan, Iran, 2010".  

18) Head project in: '' The Prevalance of Anti HEV-IgG in Hemodialysis Patients and Control Group and Relation of Relative Risk Factors''.   

19) Head project in: '' The Comparison of H.pylori prevalence in hemodialysis patients and healthy ones and associated risk factors''.    

20) Head project in: "Seroepidemiology and Risk Factors of HIV Infection in Prison's IVDUs in Isfahan Province".        

 21) Head project in: "Prevalence of infectious rate and identification of bacteria in febrile renal transplant recipients by RT-PCR".      

22) Co- operate in: "The prevalence of Toxoplasmosis in Isfahan province".  

23) Co- operate in: "The   prevalence of  cytomegalovirus infection in people in  Isfahan province".  

24) Co- operate in: "A pilot study for Surveillance of acute respiratory infections among outpatients in Isfahan city (2009-2010) ".

25) Co- operate in: "Prevalence of hepatitis B, C, HIV infections and HBs antibody titer among private and governmental laboratories' staff in Esfahan city in 2009-2010".   

26) Co- operate in: "Comparison assessment of result biopsies of liver with Hepascore in patients genotypes 1" .   

27) Co- operate in: "Evaluation of the frequency of genetic resistance to Lamivudine and Adefovir in treatment naïve patients with chronic hepatitis B infection: a pilot study".

28) Co- operate in: "Study of frequency of distribution of common Dermatophyts on mats of wrestling halls in Isfahan 2010 ". 

29) Co- operate in: "Assessment and Comparison of HBS – Antibody Rate in Type 2 Diabetic and non-diabetic  Subjects after Hepatitis B Vaccination – 2003". 

 30) Co- operate in: "Detection of HCV genome in norgesic by PCR method". 

31) Co- operate in: "Seroprevalence of and Risk factors associated with HBV,HCV and HIV virus among prisoners in Iran".

32) Co- operate in: "The comparison of seropveralence of Helicobacter Pylori in type 2 Diabetic and nondiabetic Subjects – 2003". 

33) Co- operate in: "The assessment of Nutritional and Anthropometric Status and their relation ship with CD4+ Count in HIV+/AIDS patients in Isfahan Referred to Navab Safavi Medical Center – 2005".

34) Co- operate in: "The assessment of the Relative frequency of prevalence of HBV, HCV and HIV in incarcerated juvenile in Isfahan in 2006".

35) Co- operate in: "Study of IgG Seroprevalence of Bordetella Pertusis Infections in Fresh man of Isfahan University 2007".

36) Co- operate in: "The assessment of the effects of Zinc supplements on T-Lymphocyte profiles in patients with AIDS referred to Navab- Safavi medical center -2005". 

37) Co-operate in: "The epidemiology of sexually transmitted infection and associated risk factors among women sex workers in Isfahan-Iran, 2008".

38) Co-operate in: "Prevalence of STI according to approach in men who are referred to drop-in centers (DICs), Narcotics Anonymous (NA) groups and Voluntary Consulting and Testing (VCT) center in Isfahan, 2010-2011".  

39) Co-operate in: "Prevalence of enteroviruses in CSF specimens from hospitalized patients diagnosed with meningitis/encephalitis with Real Time PCR in Isfahan city hospitals 2010-2011".

40) Co-operate in: "Frequency of aspergillus spp in bronchoalveolar lavage samples by real time time PCR in respiratory ICU at Al_ Zahra hospital-2010".

41) Co-operate in: "Frequency of candida albicans in bronchoalveolar lavage samples by real time PCR in respiratory ICU at Al_Zahra hospital- 2010".

42) Co-operate in: "Comparing two approaches of blood culture and 16s rDNA Real time PCR in Diagnosing Bacterial infectious of febrile neutropenic Patients at Seyedo-Shohada Hospital in Isfahan in 2010-11".

43) Co-operate in: "Comparison assessment of two methods (Real Time PCR & Culture) in detection of Candida albicans in immuno compromised patients in Isfahan city hospitals in 2010-2011 years".

44) Co-operate in: "Frequency assessment of bacterial infections in the Patients with probable Meningitis by 16 s rDNA Real –time PCR in Diagnosing of Bacterial Meningitis at Al-Zahra Hospital in Isfahan in 2010".  

45) Co-operate in: "Prevalence of Herpes simpelex virus (type 1,2) and Mycobacterium Tuberculosis in CSF specimens from hospitalized with meningitis/encephalitis with Real Time PCR in Isfahan City hospitals 2010-2011".

46) Co-operate in: "Frequency of Legionella in bronchiolar lavage samples byreal time PCR in respiratory ICU at AL-Zahra hospital -2010".

47) Co– operate in: "The Establishment of the first primary immunodeficiency Biobank in Isfahan University of Medical Sciences".

48) Co- operate in: "Evaluation & comparison of KIR genotype in Hepatitis B patients, susceptible families to hepatitis B and normal population". 

49) Co– operate in: "Etiologic assessment of pneumonia outbreak occurring in Isfahan Dastgerd prison by using  Real time PCR in 2010-2011".

50) Co– operate in: "Comparative Prevalence Infection   of Salmonella enterica serovars Typhi and Paratyphi A in gallbladder of patients with and without  biliary disease in Alzahra Hospital-Isfahan  using Molecular Methods And Culture".

51) Co– operate in: "Study of carbapene -resistance gene prevalence in Acintobacter isolates from ICU and surgery units , ALZAHRA hospital , Isfahan, Iran".

52) Co– operate in: " Isolation and identification of ESBLs, AmpC beta lactamases and Carbapenemase producing strains of Enterobacteriaceae in Al-Zahra Isfahan hospital and determination of their antibiotic susceptibility patterns".

53) C0- operate in : '' The Assessment of Hepatitis B Seroprevalnce in personers with IVDU History in Isfahan province: Community Based study" .

54) C0- operate in : ''The Relationship between Knowledge, Attitude and Caring Suevey toward HIV/AIDS patients among employed personnel in Isfahan university of medical sciences public hospitals  and health centers in the year 2012''.

55)  Co- operate in: " Prevalence of Chlamydia trachomatis and potential Risk Factors among Cervical discharges from women with Risky Social Behavior in Isfahan, Iran, 2011".   

56)  Co- operate in: "Prevalence of Chlamydia trachomatis and potential Risk Factors in urine sample of women with Risky Social Behavior in Isfahan, Iran, 2012''.

 57) Co- operate in: "Prevalence of Neisseria Gonorrhea and potential Risk Factors in urine sample of women with Risky Social Behavior in Isfahan, Iran, 2011".

 58) Co- operate in: "Prevalence of Neisseria Gonorrhea and potential Risk Factors among Cervical discharges from women with Risky Social Behavior in Isfahan, Iran, 2011".

 59) Co- operate in: "Prevalence of HPV and potential Risk Factors among Cervical discharges from women with Risky Social Behavior in Isfahan, Iran, 2012".

60) Co- operate in: "Molecular and epidemiological study of Clostridium difficile in patients with diarrhea in University hospitals (Alzahra, kashani, Gharazi, Shariati) of  Isfahan".

61) Co- operate in: "Molecular and epidemiological study of Clostridium difficile in patients with diarrhea in University hospital's intensive care units (ICU) of Isfahan".

62) Co- operate in: "Molecular study of Clostridium difficile in red meat (goat, camel, sheep or cow) sold in butcher shops in Isfahan".

63) Co- operate in: "Study on diverstiy of Nocardia spp. isolated from Isfahan hospitals' environments by application of conventional and molecular microbiological approaches".

64) Co- operate in: "Evaluation of fungal infection-candida and aspergillus species- in febrile hematological malignancies receiving chemotherapy by RT-PCR".

65) C0-operate in: ''Prevalence of Staphylococcus Aureus carriers in kindergarten’s children in Esfahan 4city 91-92''.

66) C0-operate in: ''Evaluation of fungal infection-candida and aspergillus species-in febrile renal transplant recipients by RT-PCR''.

67) C0-operate in: ''Evaluation the seroprevalence of hepatitis A immunity in South- Eastern and area of Iranian adolescents aged 14-16 and 8-12 years in 2011''.

68) C0-operate in: '' Evaluation of prevalence of Trichomonas vaginalis infection by molecular method in cervical discharges and urine samples from women with risky social behavior and potential risk factors in Isfahan, Iran, 2013''.


 

 

 Publication: Article   

1) Ataei B, Tayeri. Coetaneous Tuberculosis following BCG vaccination. Archives of Iranian Medicine, 2003; 6(4): 310-312.   

2) Pourahmad M, Javadi AA, Karimi I, Ataei B and Kassaian N. Seroprevalence of and risk factors associated with hepatitis B, hepatitis C and human immunodeficiency virus among prisoners in Iran. Infectious Diseases in Clinical Practice 2007; 15 (6): 368-372.   

3) Ataei B, Ganeii M, Javadi AA, Sadri GH. Screening and survey frequency of pulmonary tuberculosis in patients with chronic cough in Isfahan province (1376-1378). Iranian Journal of Infectious Diseases and Tropical Medicine.   

4) Ataei B, Kahdemi MR, Sadeghi A, nokhodian Z, Kassaian N. The Surrey of Hepatitis B Risk Factors in Blood Donors at Isfahan Province. Blood 2005, Vol 2, No 5.   

5) Nokhodian Z, Ataei B. The Correlation between HBe-Ag and Alanine Aminotransferase levels in chronic hepatitis B with PCR positive patients. Iranian Journal of Infectious Diseases and Tropical Medicine, 2006, Vol 11, No 32.   

6) Khademi MR, Amini M, Ataei B, Kassaian N, nokhodaian Z, Shoaei P. Comparison of HBS-Ab serum levels between patients with Type 2 Diabetes Mellitus and controls following vaccination against Hepatitis B, Journal of Isfahan Medical school 2007; 84:  65-71.   

7) Nilforoosha Zadeh MA, Jalayer T, Ataei B, Jafari F, Motavali Emami M. Efficacy of integration methods in the control of cutaneus Leishmaniasis in Imamzadeh Agha Ali Abbas in Natannz in 1996-98. Iranian Journal of Dermatology. 2003: 7 (26):78-83.   

8) Mostafavizade K, Ataei B, Rostami M, Salehi H, Karimi I, Javadi AA, Sherkat R, Emami AR, Khademi MR, Chinikar M, Mahmoodian A, Ghadiri F, Heidarzadeh A. Crime Congo Hemorhagic Fever Epidemy: A Preliminary report of Isfahan Province in Iran. Research in Medical Sciences 2002: 7 (1): 78-80.   

9) Kachouei A, Sdri H, Pharm D, Ataei B, Amini M, Harirforushan F, Ebrahimi R, Economical Feasibility of screening diabetes mellitus with the use of risk factors. Medical Journal 2001; 35 (50): 56-67.   

10) Ataei B, Labbafighasemi R, Sadri GHH, Ramezanpoor A, Saeedi A,B. A Survey on Malaria in Isfahan Province during Years 1986 to 1996. Kowsar Medical Journal. 2000, 5 (1):63-67.   

11)  Vaghef Davari f, Mazrooei AR, Ghaanei M, Ataei B, Ebrahimi GR, Sorushnia M. Performance of Osmotic Fragility Test as Premarriage Screening of Thalssemic Traits in Isfahan Health Net work. Research in Medical Sciences. 1999; 4 (4): 227-231.   

12)  Ataei B, Javadi AA, Khadimi MR. Fever of unknown origin and sub acute thyroiditis. Journal of Isfahan Medical school, 1997; 15 (49): 33-35.   

13)  Ataei B. Primary Tuberculosis of Buccal mucosa. Iranian Journal of Infectious Diseases and Tropical Medicine. 1997; 2 (6): 40-42.   

14)  Ataei B, Labbafighasemi R, Javadi AA, Karimi I, Kassaian N. Comparson of two different therapies for sputum positive for tuberculosis with Dot's strategy, Journal of Isfahan Medical school 2004-2005; 22:  44-48.   

15) Ataei B, Touluei H, Chinikar S, Darvishi M, Jalali N, et al. Seroepidemiology of Crimean- Congo hemorrhage fever the local and imported sheep  in Isfahan province, Iran, 2002. Iranian Journal Clinical Infectious Diseases. 2006, Vol 1, No 1.   

16) Karimi I, Rostami M, Chinikar S, Ataei B, Kassain N, Jalali N, Khosravi N. Seroepidemilogic survey of Crimean-Congo Hemorrhagic fever among slaughters and Butchers in Isfahan. Journal of Isfahan Medical school 2007, Vol 24, No 83.   

17) Ataei B, Araghy A, Fasihi Dast Jerdu M, Farajzadegan Z. Differentiation of Exudates from transudate pleural effusion by measuring cholesterol and Bilirubin. Armaghane-danesh 2007, Vol 12, No 3.   

18) Izadi M, Salehi H, Chinikar S, Mostafavizadeh K, Darvishi M, Jonaidi N, Ataei B, Khorvash F, et al. A Geographical Distribution Survey on CCHF Positive Antibody Ovine's of Isfahan Province in 1383-44. Journal of Military Medicine 2007; 9 (2): 97-102.   

19) Ataei B, Nokhodian Z,Javadi AA ,Kassaiean N, Shoaei P, Farajzadegan Z, Adibi P. Hepatitis E Virus in Isfahan province: a population based study. Int J Infect Dis 2008.   

20) Ataei B, Javadi AA, Nokhodian Z, Kassaian N, Shoaei P, Farajzadegan Z, Adibi P.HAV in Isfahan province: a population-based study. Tropical Gastroentology 2008; 29 (3): 160-162.   

21) Javadi AA, Ataei B, Shafei M, Nokhodian Z. Evaluation of satisfaction and its factors in patients in Emergency Departments of Isfahan province in 2005. Journal of Homa-ye-salamat 2008; 25: 17-21.   

22) Tayeri K, Kassaian N, Fadaei R, Ataei B. The prevalence of HBV, HCV and related risk factors in intravenous Drug Users  Infected With HIV. Isfahan Medical School Journal 2008; 26 (90): 273-7.   

23) Javadi A, Shafeai M, Ataei B, Nokhodian Z. Assessment of prevalence of the ambulances in Isfahan in 1384. Homa-ye-salamat 2008; 4: 24-28.   

24) Javadi AA, Ataei B, Khorvash F, Toghyani S, Mobasherzadeh S, Soghrati M. Prevalence of vancomycin resistant Enterococci colonization in gastrointestinal tract of hospitalized patients. Iranian Journal of Clinical Infectious Diseases. 2008; 3(3):137-141.  

25) Nokhodian Z, Kassaian N, Ataei B, Javadi AA, Shoaei P, Farajzadegan Z, Adibi P. Hepatitis B Markders in Isfahan, Central Iran: A Population-Based Study. Hepatitis Monthly 2009; 9(1): 12-16.   

26) Rahimi H, Vahedi H, Emadoleslami M, Ataei B. Study of IgG Seroprevalence of Bordetella Pertusis Infection in Fresh man of Isfahan University Students. Journal of Isfahan Medical school 2009; Special Issue on Health Promotion: 467-458.   

27) Ataei B, Ansari M, Yaran M, Nokhodian Z, Nejati H, Farajzadegan Z, Kasaeian N. The Prevalence of Hepatitis B, Hepatitis C and their Risk Factors in Transit Heavy Vehicle Drivers in Isfahan, Iran. Journal of Isfahan Medical school 2009; Special Issue on Health Promotion: 475-468.   

28) Khademi MR, Amini M, Ataei B, Nokhodian Z, Akbari M, Shoaei P, Kasaeian N, Noroozy A.
Is the Prevalence of Helicobacter Pylori Infection Different in Type II Diabetes Mellitus Patients and Non-diabetic Individuals?
Journal of Isfahan Medical school 2009; Special Issue on Health Promotion: 504-498.   

29) Karimi I, Ataei B, Taeri K, Kasaeian N, Komasi A. The Effects of Zinc Supplementation on T-Lymphocyte Profiles in Patients with AIDS. Journal of Isfahan Medical school 2009; Special Issue on Health Promotion :628-634.   

30) Nokhodian Z, Ataei B, Adibi P, FarajZadegan Z, Rostami S. Comparison of Quality of Life in Hepatitis B & Hepatitis C Patients. Journal of Isfahan Medical School 2009; Special Issue on Health Promotion: 604-598.   

31) Nokhodian Z, Ataei B, Kassaian N, Adibi P, Farajzadegan Z. Assemssment of quality of life in hepatitis B paients in Iran. Indian J, Gastroentrol 2009; 23 (3): 115-119.   

32) Mardani M, Keshtkar -Jahromi M, Ataei B, Adibi P. Short Roport: Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg 2009; 81(4): 675-678.   

33) Tayeri K, Radfar SR, Yaran M, Kassaian N, Nokhodian Z, Ataei B, Fadaei R. Isolation of Hepatitis C virus in Norgesic. Hepatitis Monthly 2010; 10 (1): 65-66.   

34) Ataei B, Nokhodian Z, Babake A, Shoaei P, Mohammad Zadeh M, Sadeghi S. Seroprevalence and associated Risk Factors of hepatitis B virus among street children in Isfahan, Iran. Journal of Isfahan Medical school 2010; 102: 788-797.  35)  Ataei B, Nokhodian Z, Babake A, Shoaei P, Mohammad Zadeh M, Sadeghi S. Seroprevalence of Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) infection among street children in Isfahan, Iran. Tehran University Medical Journal 2010; 11: 811-816.   

36) Ataei B, Tayeri K, Kassaian N, Farajzadegan Z, Babak A. Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors . Hepatitis Monthly 2010; 1 (3): 188-192.   

37) Karimi I, Kassaian N, Ataei B, Tayeri K, Zare M, Azadbakh L. Anthropometric Indices and Dietary Intake in HIV-infected patients. Journal of Isfahan Medical School 2010; 28 (107): 238-247.   

38) Karimi I, Kasasian N, Ataei B, Tayeri K, Zare M, Azadbakht L. Anthropometric Indices and Dietary Intake in HIV-Infected Patients. Journal of Isfahan Medical School 2010; 28(107):238-47.   

39) Javadi A, Ataei B,Koleini M, Saboori M .Central nervous system aspergillosis in an immunocompetent Patient. Neurosciences 2010; 15(3):193-195.   

40) Norouzi M ,Ghorashi S .A, Ataei B,Yaran M,Malekzadeh R,Alavian S.M,Judaki M.A,Ghamari S,Namazi A,Rahimnia R,Khedive A,Jazayeri S.M.Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province,South of  Iran.Iranian Journal of Basic Medical Sciences 2010 ;13(4):213-224.   

41) Babak A, Akhtar E, Fadaei Nobari R, Ataei B. Surveillance on the 2009 pandemic influenza A (HIN1)virus ,Isfahan,Iran.JRMS 2010;16(1):119.   

42) Nokhodian Z, Ataei B, Yaran M, Shams A, Kassaian N, Kafashian AR, Ehsani M, Adibi P. Hepatitis C in Correctional Centers: A Useful Experience. Journal of Isfahan Medical School 2011; 28(Special Issue on Hepatitis C):1577-80.   

43) Ataei B, Babak A, Yaran M, Kassaian N, Nokhodian Z, Meshkati M, Adibi P. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors. Journal of Isfahan Medical School 2011; 28(Special Issue on Hepatitis C):974-8.   

44) Fadaei Nobari R, Meshkati M, Ataei B, Heidari K, Kassaian N, Nokhodian Z, Shoaei P, Yaran M, Adibi P. Positive hepatitis C virus antibody in Cases with History of Intravenous Drug Abuse via Community Announcement: A useful Experience. Journal of Isfahan Medical School 2011; 28 (Special Issue on Hepatitis C):10-7.   

45) Ataei B, Salehi M, Javadi AA, Khorvash F, Mortazavi A, Kasaian N, Nokhodian Z, Babak A. The Frequency of High-risk Behaviors in Intravenous Drug Abusers Referred to Addiction Prohibition Centers in Isfahan, 2010. Journal of Isfahan Medical School 2011; 28(114):837-42.   

46)  Kafashian AR, Nokhodian Z, Kassaian N, Babak A, Yaran M, Shoaei P, Ataei B, Adibi P. The Experience of Hepatitis C Screening among Prison Inmates with Drug Injection History in 2008-2009. Journal of Isfahan Medical School 2011; 28(Special Issue on Hepatitis C):29-35.   

47) Meshkati M, Ataei B, Nokhodian Z, Yaran M, Babak A, Asgarianzadeh MR, Farshad M, Adibi P. Hepatitis C Screening in Isfahan Drop in Centers: An Experience Description. Journal of Isfahan Medical School 2011; 28 (Special Issue on Hepatitis C):17-24.   

48) Mobasherizadeh S, Kassaian N, Ataei B, Nokhodian Z, Adibi P. Hepatitis C Screening in Intravenous Drug Users Under Treatment with Methadone: An Action Reserch Study. Journal of Isfahan Medical School 2011; 28(Special Issue on Hepatitis C):36-40.   

49)  Ataei B, Meshkati M, Karimi A, Yaran M, Kassaian N, Nokhodian Z, Shoaei P, Adibi P. Hepatitis C Screening in Intravenuos Drug Users in Golpayegan, Isfahan through Community Announcement: Pilot Study. Journal of Isfahan Medical School 2011; 28(Special Issue on Hepatitis C):1581-6.   

50) Kassaian N, Nokhodian Z, Babak A, Ataei B, Adibi P. Hepatitis C in Patients with Multi Blood Transfusion in Isfahan, Iran. Journal of Isfahan Medical School 2011; 28(Special Issue on Hepatitis C):24-8.   

51) Ataei B, Javadi AA, Khorvash F, Fadaei R, Zakerzadeh Z, Nokhodian Z, Kassaian N. Effect of Vitamin D Supplementation on the Treatment of PulmonaryTuberculosis with Positive Sputum Smear. Journal of Isfahan Medical School 2011; 28 (113):781-6.   

52) Ataei B, Adibi A, Javadi AA, Khorvash F, Farzanefar P, Kassaian N. Comparison of Chest Radiographic Views in Patients with SmearPositive and Smear Negative Pulmonary Tuberculosis. Journal of Isfahan Medical School 2011;28 (116):1056-1061.   

53) Ataei B, Javadi AA, Khorvash F, Babak A, Amini Pozveh Z. Knowledge, Attitude and Practice of Surgeons and Surgical Residents in Disciplines Standard Precautions. Journal of Isfahan Medical School 2011; 28 (115):940-6.  

54) Shojaei H, Hashemi A, Heidarieh P, Ataei B, Daei Naseri A. Pulmonary and extra pulmonary infection caused by Mycobacterium conceptionense: the first report from Iran. J R Soc Rep 2011; 2: 31.  

55) Shojaei H, Hashemi A, Heidarieh P, Feizabadi MM, Ataei B. First Report on Isolation and Molecular Characterization of Clinical Mycobacterium setense Isolation in Asia. Jpn J Infect Dis 2011; 64: 234-236.

56) Ataei B, Khorvash F, Azadeh S, Nokhodian Z, Kassaian N, Babak A. The Prevalence of High Risk Behaviors among Women Prisoners in Isfahan, Iran. Journal of Isfahan Medical School. 2011; 150: 1-8.

57) Ataei B, Yazdani MR, Kalantari H, Yaran M, Nokhodian Z, Javadi AA, Babak A, Adibi P. Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk fac­tors among chronic HBV infection cases. Hepat Mon. 2011; 11(4): 269-272. 

58) Mousavia SA, Ataei B, Karimi I, Ashrafi K. Helicobacter pylori serum antibody titers in patients with cerebral non-cardioembolic ischemic stroke. JRMS 2011; 16(Special Issue): 407-411 

59) Kassaian N, Ataei B, Yaran M, Babak A, Shoaei P. Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors. Hepat Mon. 2011; 11(5):368-371.  

60) Mostafavi SN, Ataei B, Nokhodian Z,Yaran M, BabakA. Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. JRMS 2011; 16(4): 496-501. 

61) Rostami M, Javadi AA, Khorvash F, Mostafavizadeh K, Adibi A, Babak A, Ataei B, Meidani M, Emami Naeini AR, Salehi H, Avijgan M, Yazdani MR, Rezaei F. Thoracic computerized tomographic (CT) findings in 2009 influenza A (H1N1) virus infection in Isfahan, Iran. JRMS 2011; 16(5): 591-597.

62) Shojaei H, Rahimi-Hajiabadi H, Heidareieh P, Hashemi-Shahraki A, Emadoleslami M, Ataei B, Daei Nasero A. Molecular microbiological investigation of post-vaccination bacilli Calmette-Guerin infection in Iranian patients.

63) Javadi AB, Ataei B, Khorvash F, Babak A, Rostami M, Mostafavizadeh K, Emami Naeini A, Meidani M, Salehi H, Avijgan M, Sherkat R, Yazdani MR, Rezaei F. Clinical features of novel 2009 influenza A (H1N1) infection in Isfahan, Iran. J Res Med Sci 2011; 16 (12): 1550-1554. 

64) Chinikar S, Ghiasi SM, Naddaf S, Piazak N, Moradi M, Rezavi MR, Afzali N, Haeri A, Mostafavizadeh K, Ataei B, Khalilifard-Brojeni M, Husseini SM, Bouly M. Serological Evaluation of Crimean-Congo Hemorrhagic Fever in Humans with High-Risk Professions Living in Enzootic Regions of Isfahan Province of Iran and Genetic Analysis of Circulating Strains.

65) Kassaian N, Adibi P,  Kafashaian AR, Yaran M, Nokhodian Z, Shoaei P, Hassannjead R,Babak A, Ataei B. Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran. IJPM 2012; 3 (3): S156-S161.

66) Fadaei Nobari R, Meshkati M, Ataei B, Yazdani MR, Heidari K, Kassaian N, Nokhodian Z, Shoaei P, Yaran M, Adibi P. Identification of patients with hepatitis C virus infection in persons with background of intravenous drug use: the first community announcement-based study from Iran. IJPM 2012;3(3): S170-175.

67) Shoaei P, Zeidabadinejad L, Hassannejad R, Ataei B, Yaran M, Kassaian N, Nokhodian Z, et al. Seroprevalence of hepatitis A in patients with chronic hepatitis C in Isfahan province. IJPM 2012; 3(3): S102-S106.

68) Ataei B, Hashemipour M, Kassaian N, Hassannejad R, Nokhodian Z, Adibi P. Prevalence and risk factors of anti HCV infection in patients with beta-thalassemia in Isfahan-Iran 2012; 3 (3): S118-S123.

69) Yazdani MR, Kassaian N, Ataei B, Nokhodian Z, Adibi P. Hepatitis C virus infection in patients with hemophilia in Isfahan, Iran. IJPM 2012; 3 (3): S89-S93.

70) Nokhodian Z, Meshkati M, Adibi P, Ataei B, Kassaian N, Yaran M, Shoaei P, Hassannejad R. Hepatitis C among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors. IJPM 2012; 3(3): S118-S123.

71) Norouzi M, Ghorashi SA, Abedi F, Nejatizadeh A, Ataei B, Malekzadeh R, et al. Identification of Hepatitis B virus Surface Antigen (HBs Ag) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran. Iranian J Publ Health, 2012; 41(3):104-111.

72) Nokhodian Z, Ataei B, Kassaian N, Yaran M, Hassannejad R. Seroprevalence and risk factors of Hepatitis C virus among juveniles in correctional center in Isfahan, Iran. IJPM 2012; 3(3): S113-S117.    

73) Ataei B, Khorvash F, Salehi M, Houshmand S, Kassaian N,  Babak A, Nokhodian Z, Ataei M. The Relative Frequency of Depression and Anxiety in Patients with Hepatitis B Referring to Infectious Diseases and Tropical Medicine Research Center, Isfahan, Iran. Journal of Isfahan Medical School 2012; 29(169): 1-7.

74) Jafari N, Farajzadegan Z, Ataei B. Surveillance System for Hepatitis C infection: A practical Approach. Int  J Prev Med 2012; Special issue, S48-57.

75) Kassaian N, Ataei B, Yaran M, Babak A, Shoaei P, Ataie M.HIV and other sexually transmitted infection in women with illegal social behavior in Isfahan, Iran. Advanced Biomedical Research 2012; 1:5.

76) Ataei M, Nokhodian Z, Ataei B, Kassaian N, Yaran M, Hassannejad R. Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners. Journal of Research in Medical Sciences 2013; 18(1): 71-73.

77) Shoaei P, Zeidabadinejad L, Ataei B, Babak A, Nokhodian Z, Yaran M, Kassaian N. Seroprevalence of Hepatitis A Virus in Patients with Chronic Hepatitis B or C in Isfahan Province, Iran. Journal of Isfahan Medical School. 2012; 30(199).

78) Ataei B, Zahraei SM, Pezeshki Z, Babak A, Nokodian Z, Mosherzadeh S, Hoseini SG. Baseline evaluation of hand hygiene compliance in three major hospitals, Isfahan, Iran. J Hosp Infect.  2013 ;85(1):69-72.

79) Javadi AA, Ataei B, Yaran M, Nokhodian Z, Kassaian N, Tayeri K, et al. Prevalence of HIV infection and related risk factors in Isfahan Drop in Centers. Pak J Med Sci 2013; 29(1)Suppl:346-350.

80) Hashemipour M, Nokhodian Z, Yaran M, Ataei B, Tayeri K, Nobari RF, et al. Prevalence of HIV infection in individuals with history of intravenous drug use via community announcement in Isfahan- Iran. Pak J Med Sci 2013; 29(1)Suppl:395-398.

81) Dibaj R, Ataei B, Yaran M , Nokhodian Z, Tayeri K, Zamanimoghadam A. Prevalence of HIV infection in inmates with history of injection drug use and evaluation of risk factors, in Isfahan, Iran. Pak J Med Sci 2013;29(1)Suppl:399-402.

 

Conference Presentations:  

1) Survey and Coparatative Result of treatment of Pulmonary Tuberculosis with DOTS and Standard Regimen. The 8th Iranian Congress on Infectious Diseases and Tropical Medicine 2000; Tehran.  

2)  Survey Epidemiologic chloral in Ardestan Area and Control of chlora. The 8th Iranian Congress on Infectious Diseases and Tropical Medicine, 2000.  

3) Survey of Seroepidemiological Hydtid Cyst Disease in Kache Area and Comparative two test KASONI, IFA. Iranian 5th Congress on Infectious Diseases and Tropical Medicine, 1996: Tehran.  

4) Seroepidemiology of Crimean-Congo Hamorrhagic fever among Butchers and slaughters of the Isfahan province, Iran in 2005. 12th International Congress on Infectious Diseases, Lisbon, Portugal. June 15-18, 2008.  

5)  The prevalence of HBs Antigenemia in patients with HIV Infection in Shiraz, Iran, 12th International Congress on Infectious Diseases, Lisbon, Portugal. June 15-18, 2008.  

6)  Correlation Between HBe Ag and Alanine Aminotransferase levels in chronic Hepatitis B with PCR positive patients. 12th International Congress on Infectious Diseases, Lisbon, Portugal. June 15-18, 2008.  

7)  Assessment of Quality of life in Hepatitis C patients in Isfahan Iran. International Congress on Infectious Diseases, Lisbon, Portugal. June 15-18, 2008.  

8) HBV Markers in Central of Iran, 13th International Congress on Infectious Diseases, KualaLumpur, Malaysia, June 19-22, 2008.  

9)  Knowledge and practice about Aids. Hepatitis B and C in Barbers. 13th International Congress on Infectious Diseases, KualaLumpur, Malaysia,June 19-22, 2008.  

10) Seroepidemilogy of HEV Infection in Isfahan, Iran. A Community-Based study, 13th International Congress on Infectious Diseases, KualaLumpur, Malaysia, June 19-22, 2008.  

11) Pleural Fluid Cholestrol and Bilirubin value in Diagnostic of Exudative from Transudative pleural Effusion, 13th International Congress on Infectious Diseases, Kuala Lumpur, Malaysia, June 19-22, 2008.  12) Prevalence of vancomycin-resistant enterococci colonization in gastro-intestinal tract of hospitalized patients in a hospital, Isfahan province-Iran.18th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain 2008.  

13) Assessment of Quality of life in Hepatitis B patients. 13th International Congress on Infectious Diseases, KualaLumpur, Malaysia,June 19-22, 2008.  

14)  Assessment of HBV, HCV and their risk factors in HIV positive addict. The 1st National Congress of Infection in Addicts, 2008, Februaray, IRAN.  Risk Factors for Hepatitis B in Isfahan, Iran. 13th International Congress on Infectious Diseases, Kuala Lumpur, Malaysia, June 19-22, 2008.  

15) Comparison of HBs-Ab serum levels between patients with Type 2 Diabetes Mellitus and Controls Fallowing vaccination against Hepatitis B. The 1st National Congress of Endocrine & Metabolism updates, 2007, Isfahan, IRAN.  

16) Seroepidemiology of Crimean-Congo hemorrhagic fever in domestic animals in central area if Iran. 17 th European Congress of clinical Microbiology and infectious Diseases, MÜnchen, 31 March-3 April, 2007.  

17) Brucella Multi-organ involvement in a patients with negative serologic tests: Case report. 17th European Congress of clinical Microbiology and infectious Diseases, MÜnchen, 31 March-3 April 2007.  

18) The assessment of knowledge about AIDS and its prevention on Isfahan high school students. 17th European Congress of Clinical Microbiology and Infectious Diseases, MÜnchen, 31 March-3 April 2007.  

19) Delta hepatitis infection in patients with chronic hepatitis B infection in Isfahan, Iran. 19th European Congress Microbiology and Infectious Diseases, Helsinki, Finland 16-19 may 2009.  

20) Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan -Iran: Seroprevalence and associated factors. 8th congress of Eurupran Federation of Internal Medicine. Turkey May 27-30, 2009.  

21) Rrcognition of hepatitis V virus in a type of drug that is abused by intravenous drug users in Iran. Helsinki, Finland 16-19 may 2009. 

22)  Anti-HCV positivity in Cases with History of Intravenous Drug Abuse via Community Annoucenent: A useful Experience. Iranian Association of Gastroentrology and Hepatology, Tehran  2009. 

23) Assessment of thyroid dysfunction (Anti-TPO Abs & TSH Tests) in patients with hepatitis C virus infection treated with combination interferon-α 2 β and Ribavirin , 2nd Iranian Congress of Endocrine & Metabolism Updates. Isfahan-Iran,22-24 April 2009. 

 

Abstracts in Journals:  

1) Ataei B, Nokhodian Z, Javadi AA, Shoaei P, Kassaian N , Farajzadegan Z, Adibi P. HBV markers in central of Iran. 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.  

3) Ataei B, Araghi A, Kassaian N, Nokhodain Z, Karimi I. Pleural Fuild cholesterol and bilirubin value in diagnostic of exudative from transudative pleural effusion. 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.  

4) Ataei B, Saidi A, Kassaian N, Nokhodian Z, Jalali M. Knowledge and practice about AIDS, hepatitis B and C in barbers. 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.  

5)  Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, Adibi P. Seroepidemiology of hepaitits E virus infection in Isfahan-Iran: a community-based study. 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.  

6)  Khademi M, Amini M, Ataei B, Kassaian N, Nokhodian Z, Shoaei P. The comparison of HBs-Ab serum levels between patients with type 2 diabetes mellitus and healthy non-diabetic ones following vaccination. International Scientific Exchange. 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.  

7)   Kassaian N, Pourahmad M, Nokhodian Z, Amini M, Ataei B. Risk factors for hepatitis B in Isfahan, Iran. 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.  

8)   Nokhodian Z, Ataei B, Kassaian N, Adibi P. Assessment of quality of life in hepaitis B patients. 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.  

9) Ataei B, Kalantari H. Soleimani S, Javadi A, Adibi P, Yaran M, Nokhodian Z. Delta hepatitis infection in patients with chronic hepatitis B infection in Isfahan, Iran. 19th European Congress Microbiology and Infectious Diseases, Helsinki, Finland 16-19 may 2009.  

10) Ataei B, Kassaian N, Tayeri K, Farajzadegan Z. Hepatitis B and among patients infected with Human Immunodeficiency Virus in Isfahan- Iran: Seroprevalence and associated factors. 8th congress of European Federation of Internal Medicine European Journal of Internal Medicine 2009; 20S: S1-S283.  

11) Ataei B, Nokhodian Z, Babak A, Shoaei P, Mohammadzadeh S, Sadeghi M, Ataei M. Seroprevalence of Hepatitis C (HCV) infection among street children in Isfahan, Iran. The 21st Conference of the Asian Pacific Association for the Study of the Liver. Thailand, 17-22 February 2011. Hepatol Int (2011); 5: 3-558.

12) Ataei B, Nokhodian Z, Kassaian N, Babak A, Shoaei P, Meshkati M, Ataei M, Adibi P. Hepatitis C in IVDUs  in Isfahan, Iran, 2008. The 21st Conference of the Asian Pacific Association for the Study of the Liver. Thailand, 17-22  February 2011. Hepatol Int (2011); 5: 3-558.

13) Ataei B, Shoaei P, Nokhodian Z, Babak A, Yaran M, Kassaian N, Ataei M, Foroughifar M. Prevalence of hepatitis B and C Virus in barbers, Isfahan (Iran), 2007. The 21st Conference of the Asian Pacific Association for the Study of the Liver. Thailand, 17-22  February 2011.  Hepatol Int (2011); 5: 3-558.  

14) Fadaei Nobari R, Adibi P, Ataei B, Kassaian N, Meshkati M, Babak A, Nokhodian Z, Yaran M. Anti-HCV Positivity in Cases with History of Intravenous Drug  Abuse via Community Announcement: A useful Experience. The 21st Conference of the Asian Pacific Association for the Study of the Liver. Thailand, 17-22  February 2011. Hepatol Int (2011); 5: 3-558.  

15) Zeidabadi Nejad L, Shoaei P, Babak A, Yaran M, Ataei B, Foroughifar M, Kassaian N. Prevalence of hepatitis A in Iranian patients with chronic hepatitis B or hepatitis C infection    .  The 21st Conference of the Asian Pacific Association for the Study of the Liver. Thailand, 17-22 February 2011. Hepatol Int (2011); 5: 3-558.

16) Kassaian N , Ataei B, Babak A, Nokhodian Z, Adibi  P, Mohammadzadeh S. Hepatitis C in Patients with Multi Blood Transfusion in Isfahan, Iran.  The 21st Conference of the Asian Pacific Association for the Study of the Liver. Thailand, 17-22  February 2011. Hepatol Int (2011);5: 3-558.

17) Shoaei P, Rahimi H, Yaran M, Babak A, Ataei B, Foroughifar M. Hepatitis A seropositivity among fresh man medical students of Isfahan (Iran), 2007. The 21st Conference of the Asian Pacific Association for the Study of the Liver. Thailand, 17-22  February 2011. Hepatol Int (2011); 5: 3-558.

18) Karimzadeh H, Norouzi S, Alavian S, Malekzadeh R, Montazeri G, Nejatizadeh A, Zii F, Adibi F, Ataei B, et al. Molecular Epidemiological study of Hepatitis B virus in Iran, the Unique Pattern of Genotypic Homogeneity; Results of a Nationwide study. The 21st Conference of the Asian Pacific Association for the Study of the Liver. Thailand, 17-22 February 2011. Hepatol Int (2011); 5: 3-558.

 

 

 

 

 

Co- operate in: Evaluation & comparison of KIR genotype in Hepatitis B patients, susceptible families to hepatitis B and normal population.

Co – operate in: The Establishment of the first primary immunodeficiency Biobank in Isfahan University of Medical Sciences.

Co – operate in: Etiologic assessment of pneumonia outbreak occurring in Isfahan Dastgerd prison by using  Real time PCR in 2010-2011.

 

porsesh

نظرسنجي

نظر شما در مورد سايت چيست ؟